Principles of care for the diagnosis and treatment of von Willebrand disease
Open Access
- 30 April 2013
- journal article
- review article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 98 (5), 667-674
- https://doi.org/10.3324/haematol.2012.077263
Abstract
Von Willebrand disease is a common autosomal inherited bleeding disorder caused by quantitative or qualitative defects of von Willebrand factor, a multi-adhesive protein that binds platelets to exposed subendothelium and carries factor VIII in circulation. As a result of von Willebrand factor deficiency or abnormality, levels of factor VIII, the protein deficient in hemophilia A, may be variably reduced. Clinical manifestations are mainly represented by mucous membrane and of soft tissue bleeding. Their severity is variable depending on the degree of von Willebrand factor and factor VIII reduction. While a clear-cut diagnosis is easy in severe von Willebrand factor reductions, the advantage of pursuing a definite diagnosis in mild or dubious cases should be weighed against the risk of over-medicalization. The aim of treatment is to correct the dual defect of hemostasis caused by the abnormal/reduced von Willebrand factor and the concomitant deficiency of factor VIII. Desmopressin is the treatment of choice for type 1 von Willebrand disease patients with factor VIII and von Willebrand factor levels of 10 U/dL or over who have proved responsive to a test-infusion with the compound. Von Willebrand factor/factor VIII concentrates are needed when desmopressin is ineffective (mainly type 2 and 3 von Willebrand disease).Keywords
This publication has 62 references indexed in Scilit:
- Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN)Haemophilia, 2012
- Different bleeding risk in type 2A and 2M von Willebrand disease: a 2‐year prospective study in 107 patientsJournal of Thrombosis and Haemostasis, 2012
- ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disordersJournal of Thrombosis and Haemostasis, 2010
- Quantitation of bleeding symptoms in children with von Willebrand disease: use of a standardized pediatric bleeding questionnaireJournal of Thrombosis and Haemostasis, 2010
- Pregnancy and delivery in women with von Willebrand's disease and different von Willebrand factor mutationsHaematologica, 2009
- How I treat von Willebrand diseaseBlood, 2009
- Hepatitis A and B immunization for individuals with inherited bleeding disordersHaemophilia, 2009
- Bleeding scores in inherited bleeding disorders: clinical or research tools?Haemophilia, 2008
- Hyperhomocysteinemia: cause or effect of disease?Blood, 2005
- Use of Recombinant Factor VIla (NovoSeven®) in the Treatment of Two Patients with Type III von Willebrand’s Disease and an inhibitor against von Willebrand FactorPathophysiology of Haemostasis and Thrombosis, 1996